Raubenheimer, P. J., Cushman, W. C., Avezum, A., Basile, J., Conget, I., Dagenais, G., Hoover, A., Jansky, P., Lanas, F., Leiter, L. A., Lopez‐Jaramillo, P., Pogosova, N., Probstfield, J., Rao‐Melacini, P., Rydén, L., Sheu, W. H., Temelkova‐Kurktschiev, T., & C. Gerstein, H. (2022). dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial. Diabetes, obesity & metabolism, 24(4), 704–712. http://access.bl.uk/ark:/81055/vdc_100152641467.0x000027